Insider Selling at American Vanguard Co.

On December 13th, Peter Eilers, an insider at American Vanguard Co. (NYSE:AVD), sold 3,000 shares of the company's stock. The shares were sold at an average price of $5.35 each, leading to a total transaction value of $16,050. Following this sale, Eilers now directly holds 38,177 shares in the company, which are valued at approximately $204,246.95. This transaction represents a 7.29% decrease in his position within American Vanguard. The details of this sale were disclosed in a filing with the SEC, available for public access.

Recent Stock Performance

As of midday trading on Tuesday, shares of American Vanguard (NYSE:AVD) saw a drop of 5.9%, decreasing by $0.29 to reach a price of $4.64. The trading volume for the day reached 193,177 shares, while the average volume typically stands at 260,219 shares. American Vanguard currently has a market capitalization of $133.58 million and a PE ratio of -4.78, with a beta of 0.89. Over the past fifty days, the stock has averaged $5.63, and its two-hundred day moving average stands at $6.74. The company’s shares have experienced a fifty-two week low of $4.63 and a high of $14.28. Financial indicators show a quick ratio of 0.79, a current ratio of 1.89, and a debt-to-equity ratio of 0.55.

Institutional Investment Activities

There has been notable activity among large investors concerning American Vanguard's stock. For instance, Nisa Investment Advisors LLC increased its stake significantly by 7,554.5% during the second quarter, now owning 4,210 shares valued at approximately $36,000 after purchasing an additional 4,155 shares. Similarly, Point72 DIFC Ltd raised its position by 195.7% in the same quarter, acquiring 5,080 shares currently valued at around $44,000. Additionally, SG Americas Securities LLC has taken a new stake worth about $56,000. Quantbot Technologies LP has also increased its holdings by 64.5%, bringing their total to 11,291 shares valued at $60,000 after acquiring 4,429 shares. In total, institutional investors and hedge funds hold 79.04% of American Vanguard's stock.

Analyst Recommendations

In terms of analyst ratings, StockNews.com upgraded American Vanguard from a "sell" to a "hold" rating on September 25. Current analyst sentiment on the stock shows a consensus 'Moderate Buy' rating, with one analyst recommending a hold and four recommending buy. According to MarketBeat, the consensus price target for American Vanguard is set at $16.67.

About American Vanguard

American Vanguard Corporation, through its various subsidiaries, focuses on the development, manufacturing, and marketing of specialty chemicals that cater to agricultural, commercial, and consumer needs both domestically and internationally. Their product range includes insecticides, fungicides, herbicides, soil health products, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, available in liquid, powder, and granular forms for various applications including crop protection, turf and ornamental plant care, as well as human and animal health protection.

Insider, Selling, Stocks